About Us

Our Story

At Matregenix, we have always been fascinated by the potential of nanofibers and their ability to revolutionize a wide range of industries. From filtration to biomedical applications, we knew that the tiny fibers had the power to make a big impact.

In 2018, we began our journey in Boston as a small company with a big vision -to design, develop, and manufacture highly tunable nanofibrous materials that could be customized to meet the specific needs of various applications. Our R&D efforts have led us to create a range of materials that can be used in a wide range of fields. We then expanded our manufacturing capabilities by relocating our operation to Irvine, California.

But we didn't stop there. We realized that to truly unlock the potential of nanofibers, we needed to provide manufacturers with the tools and resources they needed to bring these innovations to life. That's why we began building state-of-the-art electrospinning machines and offering contract development and manufacturing services to help manufacturers turn their ideas into products.

Today, Matregenix has grown into a leading provider of nanofibrous materials and electrospinning equipment. We have a strong reputation for our ability to customize our materials to meet the unique needs of our clients, and our contract development and manufacturing services have helped many companies bring their nanofiber innovations to market.

We are proud of what we have accomplished, but we know that there is still so much more to be done. We are constantly pushing the boundaries of what is possible with nanofibers, and we are committed to continuing to innovate and evolve as a company.

Join us on our journey to unlock the potential of nanofibers and make a big impact in various industries

Pic_32_png (1)


Sherif Soliman

Ph.D., MBA - Chief Executive Officer

Set up an appointment with me
Sherif Soliman

Ph.D., MBA - Chief Executive Officer

Highly passionate, and quality-driven, Dr. Sherif Soliman is a leading Material Scientist and founder of Matregenix. For over 15 years, Sherif has built on his extensive experience in biomaterials and nanofibers research and has planned, designed, and executed numerous nanofibrous polymeric structures for medical applications. His historical achievements in the creation of tissue scaffolds, as well as his expertise in medical device manufacturing, have earned him a reputation as a trusted partner to thought leaders and industry experts throughout the globe. One of his most rewarding achievements took place when a tissue-engineered scaffold he designed and developed became the first synthetic whole organ in medical history to be implanted into a patient.

As a native of the Sinai desert of Egypt, Sherif felt called to make difference beyond his home country and has always admired medical innovations and the strong correlation between science and engineering.

Sherif holds a Ph.D. in Material Science and Engineering from the University of Rome Tor Vergata, though much of his research was conducted as a visiting research fellow at Harvard Medical School. Following that, Sherif completed postdoctoral fellowships, the first one at MIT, and the second was an eminent T32 fellowship from NIH at Princeton University. Sherif also graduated from the Executive MBA program at Questrom School of Business and earned a BS in Biomedical Engineering. He holds several patents and has authored many peer-reviewed research papers in top tier journals. Recently, Sherif volunteered to author a new ASTM guideline for the characterization of fiber-based scaffolds for tissue engineering medical products.

When he’s not in the office, Sherif enjoys spending time with his wife and three children, being outdoors, and playing soccer as much as he can.

Set up an appointment with me
image 10
Kevin Guo

Ph.D. - Chief Operating Officer

Set up an appointment with me
Kevin Guo

Ph.D. - Chief Operating Officer

Dr. Guo is an exceptionally innovative Research and Development Scientist with a mastery in nanotechnologies and microfluidic fabrication. With over eight years of multidisciplinary research experience, Kevin has profound expertise in scientific research, laboratory management, analytical technology, scientific literature, and instrumentation, making him a suburb resource to cultivate ideal operational improvements that foster business growth.

Evin brings a very thunderous, naturistic approach to the Matregenix culture. He has always been ardent about the environment and protecting the planet, and aims to create a sustainable future using novel technologies. Because Kevin has been so powerfully motivated by this rooted mission throughout his life, while earning his Ph.D. in Chemical Engineering from the University of Wyoming, he designed all his experiments and tracked his Department of Energy projects in order to mitigate climate change. As someone with a passion for the environment and being at the forefront of medical innovation, it is no secret that Kevin genuinely admires his roles, and is continuously improving himself both personally and professionally to deliver valuable, scientific advancements that result in lasting impacts for the human race.

Set up an appointment with me
image 11
Ed O’Sullivan

J.D., MBA- Director of Business Development

Ed O’Sullivan

J.D., MBA- Director of Business Development

An entrepreneur with years of experience building companies and buying and selling businesses, Edward O’Sullivan has worked with and has counseled numerous start-ups and small enterprises with their growth strategies. For over 17 years, Mr. O’Sullivan has owned and operated Payer Tech, an IT company which provides claims transaction services to the health care insurance community.

Advisory Board

Michael Francis


Dr. Francis, Asante Bio CEO, co-founded Embody Inc, sold to Zimmer Biomet for $275M. He invented platform electrospinning and led R&D to commercialization. He secured $25M in DARPA, NIH and NSF grants, and raised $32M in investor funds. With 80+ patents, he has led teams developing advanced regenerative medicine and nanotechnology from concept to clinic.

image 12 (1)
Mathew Becker


Dr. Becker is the Hugo L. Blomquist Distinguished Professor at Duke University where his team works to address unmet needs at the interface of materials, chemistry and medicine.

image 12 (2)
Fauad Hasan

Fauad is a chemical engineer with over 22 years of experience in the biopharmaceutical and medical device industry. He was instrumental in securing a licensing deal with Glaukos for Attillaps Pharmaceuticals, and previously served as Co-Founder, President and CEO of Bonti, which was acquired by Allergan for $195 million.

image 12 (3)
Omer Merhi


Former head of clinical and project management of Smith & Nephew, Sobi, Abiomed, Novartis, Abbott, Boston Scientific and 3M.

image 12 (4)
Kelly Kambs

Ph.D., MBA

Experienced Chief Operating Officer with a demonstrated history of working in the construction industry. Strong operations professional skilled in Negotiation, Business Planning, Operations Management, Sales, and Pricing Strategy.

image 12 (5)
Mohamed Kamel,


Dr. Kamel is licensed to practice dentistry in Massachusetts and Illinois. Dr. Kamel also worked in Biomedical Engineering research, with interest in the field of tissue engineering, nano-scaffolding and stem cells bioengineering. He has a bachelor’s and a master’s degree in Biomedical Engineering from Boston University.

image 12 (6)
Samir Shreim


Dr. Shreim is an entrepreneur, scientist, and inventor specializing in medical sensing and diagnostic technologies. He is currently leading Aly Development, LLC, an Engineering consulting firm.

image 12 (7)
Marco C. Bottino


Dr. Bottino holds the position of Associate Professor (tenured) in the Department of Cariology, Restorative Sciences, and Endodontics at the University of Michigan School of Dentistry.

image 12 (8)
JP Powers


JP Powers has over 15+ years of experience working in investment management. Experienced Portfolio Manager with a demonstrated history of working in the law practice industry. Strong finance professional skilled in Portfolio Management, Asset Management, Investment Strategies, Fixed Income, and Equities.